Regeneron Pharmaceuticals Inc (REGN)
968.70
+12.94
(+1.35%)
USD |
NASDAQ |
May 09, 16:00
Regeneron Pharmaceuticals Total Assets (Quarterly): 34.37B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 34.37B |
December 31, 2023 | 33.08B |
September 30, 2023 | 32.16B |
June 30, 2023 | 30.66B |
March 31, 2023 | 30.06B |
December 31, 2022 | 29.21B |
September 30, 2022 | 27.68B |
June 30, 2022 | 27.21B |
March 31, 2022 | 26.35B |
December 31, 2021 | 25.43B |
September 30, 2021 | 23.67B |
June 30, 2021 | 21.49B |
March 31, 2021 | 17.77B |
December 31, 2020 | 17.16B |
September 30, 2020 | 16.08B |
June 30, 2020 | 14.43B |
March 31, 2020 | 15.76B |
December 31, 2019 | 14.81B |
September 30, 2019 | 13.94B |
June 30, 2019 | 13.17B |
March 31, 2019 | 12.85B |
December 31, 2018 | 11.73B |
September 30, 2018 | 10.81B |
June 30, 2018 | 9.952B |
March 31, 2018 | 9.373B |
Date | Value |
---|---|
December 31, 2017 | 8.764B |
September 30, 2017 | 8.701B |
June 30, 2017 | 8.106B |
March 31, 2017 | 7.817B |
December 31, 2016 | 6.973B |
September 30, 2016 | 6.828B |
June 30, 2016 | 6.205B |
March 31, 2016 | 5.904B |
December 31, 2015 | 5.609B |
September 30, 2015 | 5.183B |
June 30, 2015 | 4.527B |
March 31, 2015 | 4.199B |
December 31, 2014 | 3.838B |
September 30, 2014 | 3.739B |
June 30, 2014 | 3.456B |
March 31, 2014 | 3.260B |
December 31, 2013 | 2.951B |
September 30, 2013 | 2.640B |
June 30, 2013 | 2.378B |
March 31, 2013 | 2.276B |
December 31, 2012 | 2.080B |
September 30, 2012 | 1.661B |
June 30, 2012 | 1.458B |
March 31, 2012 | 1.350B |
December 31, 2011 | 1.324B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
13.17B
Minimum
Jun 2019
34.37B
Maximum
Mar 2024
23.22B
Average
24.55B
Median
Total Assets (Quarterly) Benchmarks
Vertex Pharmaceuticals Inc | 23.92B |
Amgen Inc | 92.98B |
Eli Lilly and Co | 63.94B |
Moderna Inc | 16.73B |
Gilead Sciences Inc | 56.29B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 7.378B |
Shareholders Equity (Quarterly) | 26.99B |
Debt to Equity Ratio | 0.0735 |
Current Ratio | 5.27 |
Net Debt Paydown Yield | -0.00% |